westlake village biopartners

A Thousand Oaks startup that is creating gene therapies aimed at permanently treating devastating diseases like Alzheimer's announced Thursday it received $140 million in capital.

Capsida Biotherapeutics is joining the gene therapy craze with small encapsulated viruses known as adeno-associated viruses, which can target specific cells in the body to treat diseases. The method is similar to the one used by pharma companies that create coronavirus vaccines.

Read more Show less

Westlake Village BioPartners, the two-year-old venture capital firm founded by former Amgen executives and focused on bioscience startups named Peter Calveley its chief operating officer on Wednesday.

A former executive at health care industry investment bank SVB Leerink, Calveley will lead the firm's daily operational functions and guide the company's portfolio of young life science startups, many of which started in 2018 through strategic business decisions.

Read more Show less

On this week's episode of LA Venture, hear from Sean Harper, founding managing director of Westlake Village BioPartners, which has two new funds totaling $500 million that's catalyzing the L.A. biotech ecosystem. Harper is the former head of research and development at biopharmaceutical company Amgen. He shares his focus on therapeutics to improve human lives and starting Westlake with Beth Seidenberg.

Read more Show less

Trending